In August 2024 Polish tennis player Iga Świątek tested positive for trimetazidine, a banned heart medication. An investigation by tennis’s anti-doping organization, the International Tennis Integrity Agency (ITIA), determined that she had inadvertently ingested the substance via an over-the-counter melatonin medication. Świątek ultimately served a one-month suspension from competition for the infraction.